## PLTR: Palantir Technologies Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.4% in lower entry zone (3.0-6.0%), top 8% cross-sectional ranking. Short-term MRS_5 (2.0%) confirms momentum alignment. Outperforming sector by 3.2%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($177.62)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Is Tech Coming Back Strong To End The Year? RTX, Palantir, Pan American Silver In Focus**
- Source: Investor's Business Daily | 20251220T110908 | Somewhat-Bullish | Relevance: 97%
- Justin Nielsen and Mike Webster discuss Friday's market action and spotlight key stocks like RTX, Palantir, and Pan American Silver in "Stock Market Today." The article explores whether technology stocks are poised for a strong finish to the year. This piece is part of Investor's Business Daily's market analysis content.

**2. BigBear.ai Stock: A Winning or Losing AI Investment Opportunity?**
- Source: Finviz | 20251220T131000 | Somewhat-Bullish | Relevance: 91%
- BigBear.ai, an AI-driven analytics provider, is outperforming the market but experienced a 20% revenue drop in Q3 2025 due to decreased U.S. Army programs. While it shares similarities with Palantir Technologies as a government contractor using AI, BigBear.ai’s customized solutions make it harder to scale compared to Palantir's flexible platform. The article questions whether BigBear.ai can replicate Palantir's success, suggesting it's a "second-tier opportunity" in the AI investment space despite a recent acquisition aimed at scaling.

**3. Can Trump’s Cannabis Rescheduling Order Reignite Canopy Growth’s Prospects in 2026?**
- Source: NAI500 | 20251221T230952 | Neutral | Relevance: 63%
- U.S. President Donald Trump signed an executive order to reclassify cannabis from Schedule I to Schedule III, the most significant shift in U.S. cannabis policy since 1970. This change aims to remove barriers to medical research and alleviate long-standing financial and tax burdens on the cannabis sector, potentially benefiting companies like Canopy Growth (TSX:WEED). While Canopy Growth has shown some modest improvements in its financials and its stock saw a surge, its long-term recovery depends on enhancing profitability, streamlining operations, and capturing market share amidst a policy change that is considered a "partial victory" rather than full federal legalization.

**4. What Veritone, Inc.'s (NASDAQ:VERI) 27% Share Price Gain Is Not Telling You**
- Source: Simply Wall Street | 20251221T130912 | Neutral | Relevance: 62%
- Veritone, Inc. (NASDAQ:VERI) has seen a 27% share price rebound in the last month, contributing to a 118% increase over the last year. Despite this, its P/S ratio of 4.7x is only in line with the industry median, which might not be justified given its slow revenue growth and a 39% drop over three years. While analysts forecast 23% annual revenue growth, this is lower than the industry average of 31%, suggesting a potential misalignment between the current P/S ratio and future growth outlook.

**5. RTX, Stock Of The Day, In Buy Zone With Business 'Firing On All Cylinders'**
- Source: Investor's Business Daily | 20251222T200905 | Somewhat-Bullish | Relevance: 61%
- RTX (RTX) has been named the Stock Of The Day, showing strong performance with its business "firing on all cylinders" and its stock entering a buy zone. The company's profits rose significantly this year due to robust military and commercial sales, leading to a high Composite Rating. RTX is currently in a second-stage flat base with a 181.31 buy point, indicating potential for continued growth.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 18 ($3.83M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 33.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 1 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+4.0%)
- Blackrock Inc.: 8.6% (+6.4%)
- State Street Corpora: 4.6% (+7.2%)
- JPMORGAN CHASE & CO: 3.2% (+331.2%)
- Geode Capital Manage: 2.5% (+7.4%)

### Key Risks

1. Insider selling cluster: $3.8M in recent transactions.
2. Valuation stretched: PEG 3.0x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.04 signals overvaluation risk, limited margin of safety. Forward P/E 192.0x stretched relative to 39% growth. Quality metrics strong (margin 28%). Balance sheet: strong liquidity (6.4x), low leverage (D/E 0.22). Revenue growth strong at 43% YoY. Insider selling cluster ($3.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $462.3B |
| Beta | 1.50 |
| 52W Range | $63.40 - $207.52 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.04 |
| Forward P/E | 192.0 |
| Current P/E | 267.9 |
| YoY Growth | 39.5% |
| EPS Direction | RISING |

### Technicals

MRS_10 weakening modestly (-0.6% over 5 days). Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 92nd percentile. MRS_5 at 2.0% confirms short-term momentum alignment. Outperforming sector by 3.2pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.74), confirming momentum. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.43% (CS: 92) | Strong |
| RSI_14 | 61.6 | Neutral |
| MACD Histogram | 1.74 | Bullish |
| vs SMA20 | 1.084x | Above |
| vs SMA50 | 1.076x | Above |
| vs SMA200 | 1.315x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $193.98
- **Stop Loss:** $177.62 (8.4% risk)
- **Target:** $218.52 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 73
- **Position Value:** $14,160.54
- **Portfolio %:** 14.16%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-02 (Est: $0.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.17 | $0.21 | +25.5% |
| 2025Q2 | $0.14 | $0.16 | +15.6% |
| 2025Q1 | $0.13 | $0.13 | +1.1% |
| 2024Q4 | $0.11 | $0.14 | +23.7% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*